Cellular and Humoral Immune Responses to Alphavirus Replicon Vaccines Expressing Cytomegalovirus pp65, IE1, and gB Proteins

Por Reap, Elizabeth A., Dryga, Sergey A., Morris, John, Rivers, Bryan, Norberg, Pamela K., Olmsted, Robert A., Chulay, Jeffrey D.
Publicado em 2007

Alphavirus Replicon Particles Expressing TRP-2 Provide Potent Therapeutic Effect on Melanoma through Activation of Humoral and Cellular Immunity

Por Avogadri, Francesca, Merghoub, Taha, Maughan, Maureen F., Hirschhorn-Cymerman, Daniel, Morris, John, Ritter, Erika, Olmsted, Robert, Houghton, Alan N., Wolchok, Jedd D.
Publicado em 2010

Combination of Alphavirus replicon particle-based vaccination with immunomodulatory antibodies: therapeutic activity in the B16 melanoma mouse model and immune correlates

Por Avogadri, Francesca, Zappasodi, Roberta, Yang, Arvin, Budhu, Sadna, Malandro, Nicole, Hirshhorn-Cymerman, Daniel, Tiwari, Shakuntala, Maughan, Maureen F., Olmsted, Robert, Wolchok, Jedd D, Merghoub, Taha
Publicado no Cancer Immunol Res (2014)

Development and preclinical evaluation of an alphavirus replicon particle vaccine for cytomegalovirus

Por Reap, Elizabeth A., Morris, John, Dryga, Sergey A., Maughan, Maureen, Talarico, Todd, Esch, Robert E., Negri, Sarah, Burnett, Bruce, Graham, Andrew, Olmsted, Robert A., Chulay, Jeffrey D.
Publicado em 2007